Zobrazeno 1 - 10
of 263
pro vyhledávání: '"A. M. Sieuwerts"'
Autor:
R. R. J. Coebergh van den Braak, S. ten Hoorn, A. M. Sieuwerts, J. B. Tuynman, M. Smid, S. M. Wilting, J. W. M. Martens, C. J. A. Punt, J. A. Foekens, J. P. Medema, J. N. M. IJzermans, L. Vermeulen
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background There are profound individual differences in clinical outcomes between colorectal cancers (CRCs) presenting with identical stage of disease. Molecular stratification, in conjunction with the traditional TNM staging, is a promising
Externí odkaz:
https://doaj.org/article/d6c7c6e7e2db4724b5be3c4143803535
Autor:
I. E. de Kruijff, A. M. Sieuwerts, N. Beije, W. J. C. Prager - van der Smissen, L. Angus, C. M. Beaufort, M. N. Van, E. Oomen - de Hoop, A. Jager, P. Hamberg, F. E. de Jongh, J. Kraan, J. W. M. Martens, S. Sleijfer
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundCisplatin (cDDP) has regained interest for metastatic breast cancer (MBC) patients, given the platinum sensitivity in subtypes and better manageable toxicity. Here, the primary aim was to determine whether molecular characteristics of circu
Externí odkaz:
https://doaj.org/article/3ecfd168a49445039557708262e8b2a4
Autor:
Anieta M. Sieuwerts, Wendy Onstenk, Jaco Kraan, Corine M. Beaufort, Mai Van, Bram De Laere, Luc Y. Dirix, Paul Hamberg, Aart Beeker, Hielke J. Meulenbeld, Geert‐Jan Creemers, Wytske M. vanWeerden, Guido W. Jenster, Annemieke J. M. Nieuweboer, Ron H. J. Mathijssen, Ronald deWit, John W. M. Martens, Stefan Sleijfer
Publikováno v:
Molecular Oncology, Vol 13, Iss 8, Pp 1795-1807 (2019)
The androgen receptor splice variant (AR‐V) 7 in circulating tumor cells (CTCs) is a predictor for resistance to anti‐AR‐targeted treatment, but not to taxane‐based chemotherapy in metastatic castration‐resistant prostate cancer (mCRPC). In
Externí odkaz:
https://doaj.org/article/9ca2c96fafc6462f975ce13bf278760c
Autor:
Stefan Sleijfer, John A. Foekens, John W.M. Martens, Anieta M. Sieuwerts, Jan W. Gratama, Cornelis J.H. van de Velde, Monique M.E.M. Bos, Hanneke W.M. van Laarhoven, Lonneke W. Kessels, Joan B. Heijns, Saskia van de Ven, Johan W.R. Nortier, Judith R. Kroep, Vincent T.H.B.M. Smit, Ayoub Charehbili, Mieke M. Timmermans, Bianca Mostert, Jaco Kraan, Wendy Onstenk
Clinicopathological characteristics, CTC and CEC counts, and primary tumor EpCAM and MCAM staining specified per patient.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81e8ae48db5d6c608aef49e3bf32fef5
https://doi.org/10.1158/1535-7163.22502670.v1
https://doi.org/10.1158/1535-7163.22502670.v1
Autor:
Stefan Sleijfer, John A. Foekens, John W.M. Martens, Anieta M. Sieuwerts, Jan W. Gratama, Cornelis J.H. van de Velde, Monique M.E.M. Bos, Hanneke W.M. van Laarhoven, Lonneke W. Kessels, Joan B. Heijns, Saskia van de Ven, Johan W.R. Nortier, Judith R. Kroep, Vincent T.H.B.M. Smit, Ayoub Charehbili, Mieke M. Timmermans, Bianca Mostert, Jaco Kraan, Wendy Onstenk
Legends to supplementary table 1 and figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e461d9fc0278f203b8ed494850c560b
https://doi.org/10.1158/1535-7163.22502673
https://doi.org/10.1158/1535-7163.22502673
Autor:
Stefan Sleijfer, John A. Foekens, John W.M. Martens, Anieta M. Sieuwerts, Jan W. Gratama, Cornelis J.H. van de Velde, Monique M.E.M. Bos, Hanneke W.M. van Laarhoven, Lonneke W. Kessels, Joan B. Heijns, Saskia van de Ven, Johan W.R. Nortier, Judith R. Kroep, Vincent T.H.B.M. Smit, Ayoub Charehbili, Mieke M. Timmermans, Bianca Mostert, Jaco Kraan, Wendy Onstenk
Circulating tumor cells (CTC) are detected by the CellSearch System in 20% to 25% of patients with primary breast cancer (pBC). To improve CTC detection, we investigated melanoma cell adhesion molecule (MCAM) as enrichment marker next to epithelial c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6e814638c229aa3e8cd513dd79c495
https://doi.org/10.1158/1535-7163.c.6537144.v1
https://doi.org/10.1158/1535-7163.c.6537144.v1
Autor:
Stefan Sleijfer, John A. Foekens, John W.M. Martens, Anieta M. Sieuwerts, Jan W. Gratama, Cornelis J.H. van de Velde, Monique M.E.M. Bos, Hanneke W.M. van Laarhoven, Lonneke W. Kessels, Joan B. Heijns, Saskia van de Ven, Johan W.R. Nortier, Judith R. Kroep, Vincent T.H.B.M. Smit, Ayoub Charehbili, Mieke M. Timmermans, Bianca Mostert, Jaco Kraan, Wendy Onstenk
Examples of EpCAM and MCAM staining in primary tumor tissues from core needle biopsies taken before start of neoadjuvant chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38775325c7855e3eb2a6ca7657371f04
https://doi.org/10.1158/1535-7163.22502676.v1
https://doi.org/10.1158/1535-7163.22502676.v1
Autor:
John W.M. Martens, John A. Foekens, Stefan Sleijfer, Jan W. Gratama, Yixin Wang, John Jiang, Jack X. Yu, Marcel Smid, Carolien H.M. van Deurzen, Raquel Ramírez-Moreno, Petra van der Spoel, Jaco Kraan, Vanja de Weerd, Anne Van Galen, Peter A. van Dam, Luc Y. Dirix, Jacqueline M.L. Stouthard, Felix E. de Jongh, Dieter Peeters, Joan Bolt-de Vries, Bianca Mostert, Anieta M. Sieuwerts
Supplementary Figures S1-S2 from mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::220726e6c8aa8ba99aa27bafc92afa2f
https://doi.org/10.1158/1078-0432.22442478
https://doi.org/10.1158/1078-0432.22442478
Autor:
Emile E. Voest, Jan N.M. Ijzermans, Marco J. Koudijs, Katharina Biermann, John A. Foekens, John W.M. Martens, Fried Zwartkruis, Armel Lefebvre, Marcel Smid, Anne van Galen, Salo Ooft, Zarina S. Lalmahomed, Ronne Brunekreef, Christina Stangl, Anieta M. Sieuwerts, Markus J. van Roosmalen, Mark Pieterse, Robert R.J. Coebergh van den Braak, Wigard P. Kloosterman
Colon tumor sample overview, clinical characteristics, fusion genes and KRAS, NRAS, BRAF mutation status and sequencing statistics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2a256c59c51f564473fc640548b156
https://doi.org/10.1158/0008-5472.22415336.v1
https://doi.org/10.1158/0008-5472.22415336.v1
Autor:
John W.M. Martens, Stefan Sleijfer, John A. Foekens, Anieta M. Sieuwerts, Antoinette Hollestelle, Marjolein J.A. Weerts
Purpose: In this study, we aimed to explore whether low levels of mitochondrial DNA (mtDNA) content in the primary tumor could predict better outcome for breast cancer patients receiving anthracycline-based therapies. We hypothesized that tumor cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5398d1a09c6c94116a0275d29b4bc61f
https://doi.org/10.1158/1078-0432.c.6525024
https://doi.org/10.1158/1078-0432.c.6525024